The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of chemoimmunotherapy versus immunotherapy alone in the front-line treatment of advanced non-small cell lung cancer: A systematic review and network meta-analysis.
 
Ranjan Pathak
No Relationships to Disclose
 
Gilberto Lopes
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; E.R. Squibb Sons, LLC; Janssen; Pfizer
 
Han Yu
No Relationships to Disclose
 
Wenyan Ji
No Relationships to Disclose
 
Madan Aryal
No Relationships to Disclose
 
Katherine Stemmer Frumento
No Relationships to Disclose
 
Christopher J.D. Wallis
No Relationships to Disclose
 
Zachary William Abraham Klaassen
No Relationships to Disclose
 
Henry Soo-Min Park
Honoraria - RadOnc Questions; Varian Medical Systems
Travel, Accommodations, Expenses - Brainlab; Varian Medical Systems
 
Sarah B. Goldberg
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Spectrum Pharmaceuticals
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)